Hosted on MSN17m
Novo Nordisk Shares Rebound After Friday’s $90B Wipeout: Retail, Analysts See Opportunity
Novo Nordisk shares on the NYSE rose over 5% in premarket trading Monday, reversing some losses from Friday’s plunge that ...
Eli Lilly, Novo Nordisk Stocks Rise. One of These Obesity Drugmakers Just Hit a Landmark.
Lilly and Novo still dominate the market for weight-loss and diabetes drugs, but the race is heating up in more ways than one ...
MLive48m
Bye-bye BBLs: How Y2K fashion and Ozempic created a new class divide
PERSPECTIVES: The resurgence of Y2K skin-baring fashion trends coincides with the rise of prescription weight loss drugs like ...